ALEC
Price
$2.50
Change
+$0.14 (+5.93%)
Updated
Aug 27, 12:39 PM (EDT)
Capitalization
238.86M
76 days until earnings call
ENTA
Price
$8.56
Change
-$0.09 (-1.04%)
Updated
Aug 27, 03:06 PM (EDT)
Capitalization
184.92M
82 days until earnings call
Interact to see
Advertisement

ALEC vs ENTA

Header iconALEC vs ENTA Comparison
Open Charts ALEC vs ENTABanner chart's image
Alector
Price$2.50
Change+$0.14 (+5.93%)
Volume$1.3K
Capitalization238.86M
Enanta Pharmaceuticals
Price$8.56
Change-$0.09 (-1.04%)
Volume$156
Capitalization184.92M
ALEC vs ENTA Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. ENTA commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongBuy and ENTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ALEC: $2.36 vs. ENTA: $8.65)
Brand notoriety: ALEC and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 64% vs. ENTA: 54%
Market capitalization -- ALEC: $238.86M vs. ENTA: $184.92M
ALEC [@Biotechnology] is valued at $238.86M. ENTA’s [@Biotechnology] market capitalization is $184.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 5 TA indicator(s) are bullish while ENTA’s TA Score has 7 bullish TA indicator(s).

  • ALEC’s TA Score: 5 bullish, 4 bearish.
  • ENTA’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +9.26% price change this week, while ENTA (@Biotechnology) price change was +3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.95%. For the same industry, the average monthly price growth was +13.88%, and the average quarterly price growth was +31.15%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 11, 2025.

ENTA is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+3.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($239M) has a higher market cap than ENTA($185M). ENTA YTD gains are higher at: 50.435 vs. ALEC (24.868). ENTA has higher annual earnings (EBITDA): -82.41M vs. ALEC (-125.18M). ALEC has more cash in the bank: 307M vs. ENTA (204M). ALEC has less debt than ENTA: ALEC (39.5M) vs ENTA (58M). ALEC has higher revenues than ENTA: ALEC (81.1M) vs ENTA (64.8M).
ALECENTAALEC / ENTA
Capitalization239M185M129%
EBITDA-125.18M-82.41M152%
Gain YTD24.86850.43549%
P/E RatioN/AN/A-
Revenue81.1M64.8M125%
Total Cash307M204M150%
Total Debt39.5M58M68%
FUNDAMENTALS RATINGS
ALEC vs ENTA: Fundamental Ratings
ALEC
ENTA
OUTLOOK RATING
1..100
2715
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3843
P/E GROWTH RATING
1..100
941
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALEC's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for ENTA (95). This means that ALEC’s stock grew somewhat faster than ENTA’s over the last 12 months.

ALEC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENTA (100). This means that ALEC’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's SMR Rating (98) in the Biotechnology industry is in the same range as ALEC (100). This means that ENTA’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (38) in the Biotechnology industry is in the same range as ENTA (43). This means that ALEC’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ALEC (94). This means that ENTA’s stock grew significantly faster than ALEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECENTA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWSFF0.04N/A
+7.62%
CIELO WASTE SOLUTIONS CORP.
ALPKF0.53N/A
N/A
Alpek SAB DE CV
ANPDF13.50N/A
N/A
Anta Sports Products Ltd.
HEOL15750.00N/A
N/A
Highwater Ethanol LLC
USSJY23.92-1.32
-5.25%
USS Co. Ltd.